#1705024 A Randomized Phase 3 Trial to Assess Efficacy and Safety of a Novel Formulation of Octreotide Subcutaneous Depot (CAM2029) in Patients With Acromegaly
Titel:
#1705024 A Randomized Phase 3 Trial to Assess Efficacy and Safety of a Novel Formulation of Octreotide Subcutaneous Depot (CAM2029) in Patients With Acromegaly
Auteur:
Silverstein, Julie Silverstein, Julie Ferone, Diego Freda, Pamela Katznelson, Laurence Gatto, Federico Kadioglu, Pinar Maffei, Pietro Seufert, Jochen Spencer-Segal, Joanna L. Isaeva, Elena Dreval, Alexander Harrie, Maria Svedberg, Agneta Tiberg, Fredrik